Search Results 2721-2730 of 16857 for Epilepsy (Partial Onset)
International normalized ratio (INR) and activated partial thromboplastin time (aPTT) ≤ 1.5× ULN. ... duration of the trial, starting with Screening ...
The purpose of this study is to understand the role of systemic inflammation in the genesis of seizures in susceptible children by gaining a clearer ...
... onset multiple sclerosis (POMS) patients/family participation in research and interventional therapeutic studies. Participation eligibility. Participant ...
Glycemically-defined new-onset diabetes (gNOD) with onset ≤180 days preceding enrollment. ENDPAC score ≥3, based on validated risk stratification models ...
isease, Autoimmune encephalitis, Autoimmune epilepsy, Paraneoplastic syndromes of the nervous system. Show more areas of focus for Sean J. Pittock, M.D. ...
Mayo Clinic researchers have identified a hidden "movement map" deep within the brain — a discovery that could help surgeons reduce side effects from epilepsy ...
Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Research. Bridge the Gap.
Study drug is administered 3 times daily during daytime hours with one of these doses being immediately prior to onset of ET sessions throughout the 12 week ...
Able to get a single blood drawn at Mayo Clinic in Rochester prior to beginning any medications. Exclusion Criteria: Women undergoing ovarian stimulation ...
The purpose of this study is to evaluate the median duration of therapeutic SAA levels with calaspargase pegol. Secondary end points include evaluating a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.